ABSTRACT
INTRODUCTION
In the age of genomics and proteomics, large scale data are produced by numerous scientific groups all over the world. Even now, after the race for the human genome has come to an end by the publication of the first drafts of the human genome (Venter et al., 2001; International Human Genome Sequencing Consortium, 2001 ), the total amount of available biochemical data, e.g. proteomics data, protein-protein interaction data, or information on metabolic and regulatory networks, is growing at an exponential rate.
However, because of its direct implications for pathogenicity, agricultural productivity and drug-interaction, it is the biochemistry of an organism which is of actual interest. Only few model organisms are biochemically well characterized. Inferring biochemcial information through comparative analysis of large scale array data is therefore both important and challenging. The main hurdles for an efficient exploitation are, besides the sheer amount of data, the plethora of different-and usually incompatible-data formats of the databases † . This lack of integration and interoperability gave rise to numerous bioinformatics tools (Goesmann et al., 2002; Küffner et al., 2000; and a few integrative systems (Kanehisa and Goto, 2000; Karp et al., 2000; Overbeek et al., 2000; van Helden et al., 2000 van Helden et al., , 2001b .
Nevertheless, there is a strong need for user-friendly systems allowing the user to handle and combine large and diverse data sets from different sources and to gather the required information and generate new insights from it.
A convenient user interface for the analysis of the data should support visualization since biochemical knowledge is difficult to conceptualise. For metabolic networks, most graphical interfaces (Kanehisa and Goto, 2000; van Helden et al., 2000; Appel et al., 1994; Overbeek et al., 2000) are designed to display only expert-curated static images of pathways and networks, i.e. the textbook view of things. These static representations are often inconsistent with the (more up-to-date) data found in the database itself. Current graph layout algorithms as described in Di Battista et al. (1999) are not sufficient to fulfill the special requirements and graphical conventions for metabolic networks. A few systems provide dynamically generated views of the underlying data and fulfill the special requirements and graphical conventions for metabolic pathways (Goesmann et al., 2002; Mendes et al., 2000; Karp et al., 2000; Ellis et al., 2001; Brandenburg et al., 2001 ), but they are not capable of handling data from more than one organism and multiple pathways.
We present BioMiner, a new software framework for rapid prototyping of integrative analysis tools for complex biochemical data. BioMiner was designed to simplify the implementation of tools for answering a broad range of biochemical questions. It is based on a comprehensive data model, named BioCore, representing complex and diverse biochemical data in a unified fashion. This model is currently able to handle metabolic pathways, transcription data, protein-protein interaction data, and some of the more important regulatory processes (e.g. signaling pathways). The implementation uses LEDA (Mehlhorn and Naher, 1999 ), a software library providing many standard graph algorithms. This makes BioMiner extremely helpful for rapid prototyping of biochemical software tools for the comparative analysis of complex biochemical networks.
In the following sections we give an overview of BioMiner. We then discuss the architecture and describe the biochemical data model in general. PathFinder and PathViewer are introduced before we describe the experimental results obtained. We finally discuss these results and point out future directions for the development of BioMiner.
SYSTEMS AND METHODS
BioMiner consists of two components, BioCore and yWays (see Figure 1 ). BioCore is a comprehensive biochemical data model consisting of a number of classes as well as class methods implementing core graph functions, i.e. a set of functions to be applied to these classes. yWays is the visualization component of BioMiner including a special data model and functions to layout metabolic pathways and networks.
In the following sections we use a number of technical terms like pathway, graph etc. For definitions of these terms see appendix.
Design of BioMiner
The system is designed as a three-tier application. The first tier provides interfaces to existing databases † . The second tier is responsible for the analysis of biochemical data. The result of the analysis is visualized in the third tier. For data exchange between analysis and visualization applications, † At the time of writing, a KEGG (Kanehisa and Goto, 2000) interface exists, interfaces to other databases like BIND, DIP, TRANSFAC and TRANSPATH are in preparation. BioMiner offers an XML export. For PathFinder and PathViewer, e.g. which have been implemented on top of BioMiner, an XML exchange format is provided. The analysis and visualization components are separated because of different requirements: While performance is most important for the data analysis, for the visualization it is more important to provide a rich set of user interaction possibilities and to be platform independent. The analysis part is implemented in C++ using LEDA (Mehlhorn and Naher, 1999) , a library which supplies many of the relevant data structures and algorithms. The visualization part is implemented in JAVA. This ensures availability for a wide variety of platforms. We used the JAVAbased library yFiles (Wiese et al., 2001 ) which provides a powerful framework for visualization applications.
BioCore
Based on a thorough analysis of the biochemical terminology and existing models (van Helden et al., 2001b (van Helden et al., , 2000 Paton et al., 2000; Rzhetsky et al., 2000) as well as on discussions with biochemists, we designed a comprehensive framework of classes to model biochemical entities. BioCore contains a large number of classes, which are sufficient to model the majority of biochemical processes of interest. We will only briefly discuss some of the central classes and refer to the documentation of BioCore (see our web page) for details.
Modeling biochemical data.
We consider all occurring processes to be some kind of event. Let us consider one of the most fundamental processes, a biochemical reaction. Obviously, all entities taking part in that event are compounds of one kind or other. The biochemical community uses a vast set of sometimes fuzzy, often overlapping terms to describe and to classify those compounds, e.g. simple ions, small molecules, amino acids, peptides etc. From that terminology, we derived a small set of rather well-defined classes describing (chemical or rather abstract) entities participating in the events: Participant serves as a base class for several derived classes like Protein or NucleicAcid on the one hand and more abstract objects like Pathway or Gene on the other hand. Substance classes which are not modeled S220 explicitly (e.g. lipids, nucleotides) are comprised in the class Compound, which provides member flags for the further characterization of its properties, i.e. a technique to use a generic object which can be further specified by setting special 'switches' depending on the kind of object to be stored. This prevents the explosion of our class hierarchy due to the large number of existing compound classes.
Each of these compounds can take part in various events, the most important one being a Reaction. In that reaction, as in all other events, each participating compound plays a certain role. Many of these roles are implicitly given by conventions for writing biochemical reactions: Reactants (or educts) are on the left-hand side of the equation, products on the right-hand side, and so on. In our model, we express this relationship through roles. Each Participant plays a certain Role in a given Event or Reaction, e.g. we can denote that substrates (educts) and products, although both being of type Participant, have different functions in an event.
A further distinction between Main Educt/Product and Side Educt/Product is, e.g. important for the PathFinder algorithm.
Participant, Role, and Event thus form the keystones of our object model. The model itself was developed using the Unified Modeling Language (UML, Booch et al. (1999) ). We assume that the reader is somewhat familiar with the notation of UML class diagrams for the remainder of this section † . Figure 2 shows the relationships of the central classes. Most classes are self-explanatory through their names. Role connects compounds and events, which allows us to model the different contextual functions a compound may have (e.g. a single compound can be an educt in one reaction, but a product of another). Modeling the role as an object also offers a convenient way for classifying and extending the set of roles a compound can play in different events. Figure 2 only shows metabolic classes; for a complete overview we refer to our web site.
BioCore and other biochemical models. Comparing existing data models described in van Helden et al. (2001b) ; Paton et al. (2000) ; Rzhetsky et al. (2000) ; Karp et al. (2000) ; Bader et al. (2001) , the aMAZE data model (van Helden et al., 2001b) seems to be the most flexible in our sense because it does not focus on one kind of biochemical interactions (like protein-protein-interactions in BIND (Bader et al., 2001) or metabolic pathways in Eco/MetaCyc (Karp et al., 2000) ) but integrates a † Just to recall the notation: Arrows with hollow triangles represent generalization, e.g. a Protein is a GenericCompound. General associations between classes are shown as lines with cardinalities. Relationships with an open diamond stand for part/whole relationships. Closed diamonds indicate that the part cannot exist without the whole. Self associations as the complex association in Figure 2 allow objects to include subobjects of same type. large variety of biochemical processes. Compared to other models, the BioCore Role object allows to model biochemical processes in a rather natural way describing the function of a participant in detail. Additionally, the number of classes and therewith the flexibility of BioCore is very high.
Graph core functions. Events in biochemistry are generally represented as networks (Michal, 1993) . One can either use very general representations (e.g. directed graphs van Helden et al., 2001a) ) or more specialized ones, like petri nets (Hofestädt and Thelen, 1998; Küffner et al., 2000) .
Our graph representation is based on LEDA graphs. In contrast to typical representations in biochemical textbooks, our graph consists of only one type of directed edges but two types of nodes. Figure 3 shows the representation of a metabolic reaction in BioMiner.
The usual representations of (metabolic) reactions in biochemical textbooks use hyperedges as given in Figure 4 . Representing a graph in such a manner, the uniqueness of direction and sequence of such an event is lost. In order to explicitly represent the direction and the sequence of the involved participants, we decided to use two types of nodes, one for events and one for participants. Edges in a BioMiner graph are directed. If (as in most cases) an event is bidirectional, two edges are inserted, one for each direction. To comprise an event node, it is connected to all its participants via several role edges. Thus, a participant node can take part in more than one event, playing different roles.
BioMiner is based on LEDA, a library offering a set of standard graph algorithms which had to be adapted to fit our graph model with two different node types. Examples are the query for a path between two arbitrary chemical compounds s and t or the enumeration of all biochemically valid paths and connections between s and t. Biochemically valid means, e.g. only sequences like substrate-enzyme-substrate are allowed.
yWays
In this section we discuss the visualization of metabolic pathways as diagrams. Although there is no standard notation for metabolic pathways, the diagrams in most publications are quite similar. We use a notation of Michal (1993) . This notation has the following properties:
• A compound † is represented by a shape (rectangle, circle, etc.) usually containing the name of the compound.
• A reaction is represented by a set of curves, connecting the compounds participating in it. All curves connecting the educts join at a single point and all curves connecting the products join at a single point. These points either coincide or are connected by a curve.
• The names of enzymes are placed near the lines representing the catalyzed reaction.
In the diagram we distinguish between main and side compounds. Whereas main compounds may be connected to multiple reactions, side compounds are always connected to exactly one reaction. Typically, the side compounds are placed near this reaction and have a smaller font than main compounds. In a diagram there may be many occurrences of the same compound, every time being side compound in a different reaction. The reason for using the side compound notation is that some compounds are ubiquitous in some network, e.g. ATP and ADP in the glycolysis. Representing these compounds by multiple occurrences makes the diagram much more readable.
The data model for the visualization can be kept very simple, since it needs to model only the visual appearance of the network and not the biochemistry behind it. We represent a metabolic network (or more general a biochemical network) by a directed hypergraph. Each occurrence of a compound in the diagram of the metabolic network corresponds to a node in the hypergraph, and each reaction to a hyperarc.
Besides the model, the layout algorithm is important to get a pleasing visualization result. The task of a layout algorithm is to calculate the geometric properties of the hypergraph such that the resulting diagram is as readable as possible. These geometric properties are the coordinates of the shapes representing nodes and the description of the curves representing hyperedges. Because it is hard to mathematically define a concept such as 'readability', a layout algorithm tries to optimize some aesthetic criteria which can be formulated mathematically. We can divide these criteria into application independent criteria, which apply to any layout algorithm regardless of its application domain, and domain specific aesthetic criteria. Application independent criteria are, e.g. the number of line crossings, the number of bends, the occupied area and the length of the edges, see, e.g. Di Battista et al. (1999) . We will concentrate now on the domain specific aesthetic criteria for diagrams of metabolic networks. The first aesthetic criterion, called partition criterion, is that the partition of a reaction into educts and products should be clear from the visualization. The second aesthetic criterion, called direction criterion, is that, if parts of the metabolic network are directed, i.e. the metabolic network contains a metabolic pathway, this should be shown on the diagram.
Layout algorithm. In this section we discuss the automatic layout algorithm for metabolic networks. The automatic layout algorithm can be roughly divided into the following phases: In the first phase we construct a graph from the metabolic network, the induced graph G. The induced graph contains a vertex for each compound and a vertex for each reaction. A compound vertex and a reaction vertex are connected by an edge if the compound is an educt or product of the reaction. In the second phase we calculate an orientation for G such that the resulting directed graph D is acyclic. In the third phase we calculate the layout of D with the hierarchic graph layout algorithm of yFiles. This graph layout algorithm is an implementation of the layered graph drawing approach for directed acyclic graphs, see, e.g. Bastert and Matuszewski (2001) for a comprehensive overview of this approach. Using a sophisticated implementation of a classical graph drawing algorithm as back end has the advantage that the application independent aesthetic criteria are optimized. It remains to handle the domain specific criteria.
The result of the graph drawing algorithm is always downward directed, i.e. all edges in the drawing are monotonically decreasing in y-direction according to the orientation of D. Therefore, the relative ordering of the compounds according to the y-coordinate depends only on the orientation which is defined in phase two. We can now define the domain specific aesthetic criteria in terms of the orientation.
• To ensure the partition aesthetic criterion, edges connecting the educts of an reaction must be oriented opposite to the edges connecting the products.
• To ensure the direction aesthetic criterion for irreversible reactions, the edges connecting educts are directed towards and the edges connecting products are directed away from the reaction vertex.
Unfortunately, the problem of minimizing the number of edges, violating one of the above criteria, is NP-hard. This follows directly from the fact that already the problem for minimizing the number of edges for the second criterion is NP-hard, which is a well known result in graph drawing see, e.g. Bastert and Matuszewski (2001) . We use a heuristics for solving this problem. It is based on depthfirst search (DFS) and has linear running time. Details can e.g. be found in Bastert and Matuszewski (2001) .
APPLICATIONS

PathFinder
As a first application of BioMiner, we developed and implemented PathFinder, a new tool for finding metabolic pathways in newly sequenced organisms. The construction of metabolic network is similar to the method described in Küffner et al. (2000) while PathFinder uses a different scoring function and another graph type. The algorithm integrates known metabolic information for a group of organisms collected from diverse data sources into a metabolic graph. This graph is built using the biochemical data model of BioMiner. On the basis of sequence similarity and graph algorithms, pathways can be predicted for newly sequenced organisms. The list of found putative pathways is then ranked by assigning weights to each generated pathway.
The input consists of the whole genome sequence of a query organism q and the metabolic information (networks) for a set of reference organisms O ref = {o 1 , o 2 , . . .}. All organisms in O ref should be closely related to q. The aim is to predict whether a known pathway between two compounds s and t in one of the reference organisms exists in the query organism as well or if possible alternative pathways can be inferred.
A pathway P = (r 1 , r 2 , . . . , r k ) is defined as a sequence of reactions † r i , where the length k of the pathway is defined as the number of reactions involved. The number of possible pathways between two given compounds s and t is often very large due to the high degree of substrate connectivity observed in metabolic graphs (Jeong et al., 2000) . We therefore limit our search to pathways of a reasonable maximum length k. A pathway may be linear or cyclic.
The PathFinder algorithm. The metabolic data available for O ref constitutes our initial metabolic graph MG(C, R, E), which contains vertices for all compounds C (substrates) and all reactions R (corresponding to enzymes), and the corresponding edges E.
To speed up the search or to exclude specific pathways, it can be useful to restrict the set of compounds included in MG to a subset of all compounds in C. Let C side the set of all side substrates (ubiquitous compounds as defined in KEGG) and C ex a set of user-defined excluded compounds. We then define three restricted compound sets
If one of these these restricted sets is used, the search graph MG s reduces from the full metabolic graph MG to the corresponding restricted graphs defined by C res and the induced reactions and edges.
The algorithm consists of four steps: 2. Refine search space in MG c : To limit our search to paths of at most k reactions, we compute the set of nodes that are reachable in k/2 reactions from s and t. All nodes outside this set cannot be part of pathways of length k or less and are deleted from MG c along with the corresponding edges. 3. Assigning weights to reactions: For each compressed reaction rc we consider its primitive reactions r i and align the enzyme sequence catalyzing r i with the whole genome of q using BLAST (Altschul et al., 1997) . We then compute the weight w(r i ) of the primitive reaction based on the p-value p max (r i ) of the best alignment computed:
We define the weight w(rc) of the compressed node as the maximum of the weights of its primitive reactions w(rc) = max
4. Pathway search: We explore all putative pathways P = (rc 1 , rc 2 , . . . , rc N ) using depth-first search and assign a weight
All putative pathways are ranked with respect to their weight and reported in that order.
Implementation status. The PathFinder algorithms are implemented and several experiments have been run (see experimental section). At the time of writing, the necessary data import filters and methods to configure the system via configuration files exist. PathFinder exports its results into ASCII text files as well as into XML data files containing the pathways identified. A graphical user interface will be implemented in the near future.
Comparison with other systems. Several systems exist that include a search for pathways between two compounds s and t. KEGG contains an algorithm to generate possible pathways of length k between two given compounds (Goto et al., 1997) . However, the resulting pathways are not organism specific and no other information than the EC number is used for computation. So the result can only give a rough overview of possible paths between s and t without biological meaning.
In Küffner et al. (2000) , a very similar method for a pathway search is implemented. Additionally to the KEGG data, other data from BRENDA (Schomburg et al., 2002) and ENZYME (Bairoch, 1999) are used. The actual algorithm is different from ours: First, a petri net containing all biochemical data is constructed. Then, all possible pathways of length k between s and t are computed, resulting in a huge number of putative pathways which then is reduced by several additional user defined and biologically motivated restrictions. In the last step, the remaining pathways are weighted by using expression data. Our algorithm starts by redefining the search space (see step 2 of algorithm description). The following edge weighting is based on sequence similarity and reduces the search space again. The resulting metabolic graph is quite small compared to the original search graph. The actual pathway search can then be performed efficiently.
In Goesmann et al. (2002) , annotation data are parsed. Based on KEGG reference pathways, enzymes that were found in the annotation data are marked in the underlying graph as well as enzymes that were not mentioned in the annotation although given in the KEGG reference pathway. Possible subways are calculated and presented to the user. Subways are defined as acyclic subpaths between external nodes with external nodes being metabolites playing distinct roles in a metabolic pathway. It is the task of the user to find appropriate DNA or protein sequences in the organism of interest to support the pathway hypothesis of the system. In aMAZE (as described in van Helden et al. (2001a) ), the metabolic network containing data from sequence databases is also represented as a graph consisting of two types of nodes. In contrast to BioMiner, no roles describing reaction nodes exist. Edges only describe substrate-reaction and reaction-product relationships. With help of expression data, those reaction nodes that are supported by fitting enzymes are marked. The algorithm then tries to link all marked reaction nodes together with the respective substrate and product nodes to form meaningful pathways. These pathways are then compared to known pathways contained in KEGG, Eco/MetaCyc and aMAZE databases.
PathViewer
PathFinder results can be exported in XML † and loaded into PathViewer, the second application we built using BioMiner. To visually compare metabolic networks and verify found pathways, PathViewer can display arbitrary parts of biochemical networks for different organisms graphically at the same time for comparison purposes. PathViewer is based on yWays and has many features, among them automatic layout of diagrams, displaying of side compounds and enzymes can be switched on/off, custamizable set of visualized organisms, coloring of reactions according to organism, and highlighting of found pathways.
These features allow the user to interactively explore the data. To get an overview over the data the user can choose not to show any details, e.g. side compounds and enzymes can be hidden. This leads to a very compact representation of the metabolic network. By zooming, the user can focus on a special part of the pathway and, if deemed useful, details can be switched on. Furthermore, an additional window can be opened which shows details of the currently selected compound or reaction. The predicted paths can be highlighted in the network in various ways.
PathViewer and other systems. Compared to other systems, PathViewer combines several advantages and adds further functionality. A number of systems for visualizing metabolic pathways are based on existing libraries. Often, these libraries were not originally designed to visualize biochemical processes. E.g., the visualization component in Goesmann et al. (2002) is based on a tool implemented to draw compiler graphs and thus results in rather unusual images that biologists are not familiar with. This visualization is restricted to reactions with a single substrate and product, and it does not support cosubstrates or -products in the drawings.
Other approaches as given in Brandenburg et al. (2001) or Karp et al. (2000) come closer to biologists demands concerning the visualization of metabolic processes. But still, as far as we know, no system exists that would allow a comfortable analysis of metabolic data integrating the visualization of calculated results with the help of a dynamic, interactive viewer. Furthermore, most systems are restricted in the input data by allowing only one organism and/or one pathway to be chosen as source of input data. Finally, often only a small part of the metabolic network can be visualized in a certain level of detail.
See appendix for figures showing screenshots of PathViewer, displaying PathFinder results described in the next section.
EXPERIMENTAL RESULTS
Currently our main data source is KEGG † . KEGG includes all necessary genome and enzyme sequences. For convenience, in the following we give the respective RefSeq numbers for NCBI when introducing organisms.
We defined different test data sets on which we ran the PathFinder algorithm. In the following, we give a short overview of the results. Details can be found on our web site. Dandekar et al. (1999) and Bork et al. (1998) discuss the plasticity of the glycolysis in various archaea and bacteria. By a comparative genome analysis and computation of elementary modes a number of alternative routes from glucose to pyruvate where identified by these groups. We used similar organism data as input. The maximum length † Version dated from 03/11/2002 of a pathway was set to ten reactions, leading from glucose (s) to pyruvate (t). To reduce the search space, the substrate set was chosen to be C res3 , thus excluding ubiquitous substrates and typical side metabolites. PathFinder results included the alternative pathways and detours given in Dandekar et al. (1999) and Bork et al. (1998) Dandekar et al. (1999) and Bork et al. (1998) ; the best sequence similarity found was less than 5 %. Thus, the standard glycolysis could not be found by PathFinder. Instead, a detour via the pentose phosphate pathway (PPP) was detected, similar to the detour described in Dandekar et al. (1999) for M. hominis ¶ , starting at β-D-fructose 6-phosphate, leading via transketolase (EC 2.2.1.1) to D-Xylulose 5-phosphate and again via transketolase back to glycolysis, namely glyceraldehyde 3-phosphate. From thereon, Pathfinder states the conversion of glyceraldehyde 3-phosphate by standard pathway via glyceraldehyde 3-phosphate dehydrogenase (EC 1.2.1.12) to 3-phospho-D-glyceroyl phosphate, followed by phosphoglycerate kinase (EC 2.7.2.3) to 3-phospho-D-glycerate and phosphoglycerate mutase (EC 5.4.2.1) to 2-phospho-D-glycerate, and finally via phosphopyruvate hydratase (EC 4.2.1.11) to phosphoenolpyruvate.
As described in the above mentioned papers, H. pylori has no pyruvate kinase (EC 2.7.1.40) which would be the next step in standard glycolysis. Instead, PathFinder proposed an alternative reaction catalysed by phosphoenolpyruvate synthase (EC 2.7.9.2), converting phosphoenylpyruvate to pyruvate, which is actually a detour via the pyruvate metabolism. Figure 6 shows the result of experiment 1 graphically.
This pathway is given as the first and top ranked in the result list and thus the most likely pathway with a pathway weight w(P) = 1. It is therewith supporting the detours described in Dandekar et al. (1999) . Detailed information can be found on our web site.
Experiment 2
In the second experiment we chose H. influenza to be q. O ref included the same strains of E. coli as given in ‡ Helicobacter pylori 26695, NCBI RefSeq NC 000915 § Escherichia coli K-12 MG1655, Escherichia coli K-12 W3110, Escherichia coli O157 EDL933, Escherichia coli O157 Sakai ¶ Mycoplasma hominis Haemophilus influenzae Rd, NCBI RefSeq NC 000907 experiment one, additionally B. subtilis, T. pallidum, Synechocystis and two strains of H. pylori * * . The top ranked pathway with a pathway weight w(P) = 1 reflects the standard glycolysis (see Figure 7) . Furthermore, the results contained variants of the PPP as described in Dandekar et al. (1999) and Bork et al. (1998) , e.g. leading from glucose via glucokinase (EC 2.7.1.2) resp. hexokinase (EC 2.7.1.1) to α-D-glucose 6-phosphate, then entering the oxidative part of the PPP with glucose-6-phosphate 1-dehydrogenase (EC 1.1.1.49) leading via D-glucono-1,5-lactone 6-phosphate to 6-phosphogluconolactonase (EC 3.1.1.31) resulting in 6-phospho-D-gluconate, followed by phosphogluconate dehydrogenase (EC 1.1.1.44) to D-ribulose 5-phosphate. This is the starting point for the non-oxidative PPP: Ribose 5-phosphate epimerase (EC 5.3.1.6) leads to D-ribose 5-phosphate, followed by transketolase (EC 2.2.1.1). Figure 8 shows the generated pathway.
Another highly ranked pathway corresponds to the Entner-Doudoroff pathway (EDP), shown in Figure 9 : Starting at α-D-glucose via glucokinase resp. hexokinase and via α-D-glucose 6-phosphate it leads with glucose-6-phosphate 1-dehydrogenase (EC 1.1.1.49) to D-glucono-1,5-lactone 6-phosphate. 6-phosphogluconolactonase (EC 3.1.1.31) outputs 6-phospho-D-gluconate. Then the two key enzymes for the EDP, phosphogluconate dehydratase (EC 4.2.1.12) and 2-dehydro-3-deoxyphosphogluconate aldolase (EC 4.1.2.14), follow. The pathway gets back to glyceraldehyde 3-phosphate, and the standard pathway is realized again. Several variants of the described and other pathways from glucose to pyruvate were identified, too. We refer to our web site.
Similarly as stated in Dandekar et al. (1999) , those results are theoretical and based only on sequence alignment. They have to be verified by experiments. Nevertheless, they can be used to direct the search for pathways in the right direction, whenever a genome of a newly sequenced organism becomes available. The integration of, e.g. expression data which will be implemented in the near future will lead to a further improvement of pathway prediction. Tables 1 and 2 give an overview of the time and space complexity based on the above described experiments † . The time consumption depends on several factors. Table 1 shows that the number of nodes and edges (and thus the search space) reduce noticable in step 1 by a factor of nearly five (nodes) resp. fourteen (edges). This is done by compressing MG and taking out side substrates and * * Helicobacter pylori 26695, Helicobacter pylori J99 † System: UltraSPARC III CPU, 750 Mhz. 8 Gbyte RAM. gcc compiler, v2.95.3 on SOLARIS 8, optimizing flag O2. manually excluded compounds. E.g. in experiment 1 the number of nodes reduces from 13 970 to 2802, the number of edges goes down from 58 119 to 4209. Table 2 points out how the time complexity for the pathway search benefits from step 2 of the algorithm. Reducing the number of nodes and edges leads to a significant performance improvement. E.g. in the case of k = 10 the number of remaining nodes in MG c can be reduced from 2802 to 1097 in only 0.05 seconds. The weighting step reduces from 54.6 minutes to 36 minutes. The pathway search needs 6.76 seconds instead of 8.06 seconds. The main reason for the time saving is the number of alignments to be performed: When MG c is not reduced by step 2, the number of nodes and edges is much larger than in the case that step 2 is applied. Furthermore, the reaction nodes MG c are compressed, i.e. each reaction node can comprise more than one biochemical reaction resulting in a number of alignments necessary per node. In the case of k = 10, the number of necessary alignments without step 2 is 2672 (see table 2), when step 2 was applied this number reduced to 1766. Table 2 shows that the time for the pathway search and the number of generated pathways grow exponentially in k.
Complexity
Limitations
PathFinder still has some limitations which we describe in the following paragraphs.
Correctness of data. Because KEGG is the only database used by PathFinder at the time of writing, the algorithm heavily depends on the correctness of the data in this database. Importing incorrect data leads to generating biochemically incorrect pathways. This cannot be pre- vented automatically, and it is the users task to evaluate the PathFinder results to exclude mistaken pathways. By integrating other data sources, the algorithm will become more robust to this kind of 'noise' in the input data.
Pathway length. The complexity of the PathFinder algorithm grows exponentially in k, the maximal length of generated pathways. Run time depends furthermore on how 'dense' the metabolic network is, i.e. how may reactions exist connecting the substrate nodes. If there are a lot of variants to convert one substrate into another, the number of putative pathways grows very fast by increasing k. Generally a number of round about 10 reactions should be sufficient to get meaningful biochemical pathways. This is a number which still results in resonable runtime and number of generated pathways. Although the data model is already capable of representing the most important regulatory processes, new classes for more complex regulatory components are under construction. Import functions for expression data from DNA micro arrays and proteomics data will be implemented soon. At the time of writing, interfaces to BIND (Bader et al., 2001) , DIP (Xenarios et al., 2002) , TRANSFAC (Wingender et al., 2001) and TRANSPATH (Schacherer et al., 2001 ) are in development.
CONCLUSION
APPENDIX DEFINITIONS
In the following we give definitions that are important in the context of biochemical pathway modeling.
The most important term in this article may be pathway. Several definitions exist, and it seems to depend heavily on the viewpoint how this term is defined. From our point of view, two definitions have to be distinguished: DEFINITION 1. A biochemical pathway is a sequence of events or reactions that lead from one compound to another. This comprises metabolic and regulatory pathways. The length k of a biochemical pathway is the number of its events or reactions.
The analysis part in our algorithm generates biochemical pathways in the sense of definition 1. Often, the term pathway is used in a more general meaning which is reflected by the next definition: DEFINITION 2. A textbook pathway is a general, named pathway as given in a tyipcal biochemical textbook. It describes the general set of reactions that have to be present in an organism to realize this pathway. A textbook pathway is generally organism independent and could be seen as a kind of reference pathway.
Examples for textbook pathways are glycolysis or TCA cycle.
KEGG (Kanehisa and Goto, 2000) pathways are pathways in sense of definition 2: KEGG contains a set of predefined pathway maps (GIF images and corresponding database files), each describing the set of enzymes necessary for the pathway to be realized. To map a KEGG reference pathway onto an organism, the user can choose an organism from a list, thereby instantiating the pathway.
Further important terms in the context of biochemical pathways are graph and network which are often used as synonyms. Mathematically, one would state:
We use the term network to describe the whole metabolic and regulatory network present in an organism. With the term graph we describe the technical representation of this network.
Mathematicians also use the term path: In the global view, the whole metabolic network (MG) is displayed. When the user chooses a pathway from the list of found pathways, all according reactions are highlighted in the graph. The user can browse through the list to see the differences between the found pathways. In the path view, only those reactions and substrates are shown that actually belong to the chosen pathway. Further subwindows show, amongst other things, the pathway as a list in the form substrate -EC number -substrate, the list of organisms, the list of all compounds with s and t being marked, an overview window, a reaction window where a selected reaction is shown in detail, and a compound window with detailed informations for a chosen compound. The user can select from different layout algorithms and a number of different parameters. The graph can interactively be rearranged by clicking an object in the graph and dragging it to a new position. Several tools for zooming, printing, image export and graph browsing are available.
DEFINITION 4. A path in a graph from vertex s to vertex t is a sequence of edges (s, v i ), (v i , v i+1 ) ,. . . (v k−2 , v k−1 ), (v k−1 , t) such that s is the start node and t is the target node. The above path has length k.
We do not distinguish between paths and pathways; following definition 1 a pathway in our meaning is a sequence of k events or reactions, leading from s to t. Although the algorithm includes weighting mechanisms and a scoring funtion to score the generated pathways, it is the task of the user to evaluate if the putative pathways are also meaningful and perhaps even textbook pathways.
We can assign weights not only to single edges but also to pathways and graphs: DEFINITION 5. The weight of a graph (pathway) is the sum of the edge weights of the graph (pathway).
A further distinction is necessary between the internal graph on which the analysis algorithms work, and the graph used for visualization. Both are distinct objects. The internal graph is a multigraph, while the vizualisation graph is a hypergraph: DEFINITION 6. A (directed) hyperedge is an (di- rected) edge which connects two or more vertices. A (directed) hypergraph is a graph consisting of (directed) hyperedges. † DEFINITION 7. A directed multigraph G is a graph whose edges are unordered pairs of vertices, and the same pair of vertices can be connected by multiple edges. † For more details of directed hypergraphs see, e.g. Gallo et al. (1993) . Using directed multigraphs to represent the biochemical network in the computer enables us to model, e.g. that a compound can take part in several reactions with different roles.
Our algorithms can cope with graphs that contain cycles:
A cycle is a path(way) starting and ending on the same vertex (compound).
The algorithm takes care of only looking for simple cycles: DEFINITION 9. A simple cycle is a cycle in which all vertices are visited exactly once except the starting vertex which is visited only twice. This is, e.g. the case for metabolic pathways like TCA cycle.
